-

$undefined

N/A

(N/A)

LENZ Therapeutics, Inc. :LENZ

Location: | Industry: | Sector:

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

432.4M

Cash

209M

Avg Qtr Burn

-14.85M

Short % of Float

22.39%

Insider Ownership

2.82%

Institutional Own.

92.72%

Qtr Updated

12/31/24

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
LNZ100 Details Eye disease, Presbyopia	PDUFA Approval decision	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Nulabeglogene autogedtemcel (nula-cel) (GPH101) Details Sickle cell disease	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.